ANIK insider transactions
Anika Therapeutics Inc. (ANIK) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ANIK
- SEC Form 4 filed by Mcleod Ian4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- EVP, General Counsel, Corp Sec Colleran David converted options into 15,837 shares, was granted 4,694 shares and covered exercise/tax liability with 6,061 shares, increasing direct ownership by 27% to 67,570 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- President and CEO Griffin Stephen D. was granted 6,412 shares, covered exercise/tax liability with 5,944 shares and converted options into 12,824 shares, increasing direct ownership by 125% to 23,963 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Blanchard Cheryl R covered exercise/tax liability with 26,832 shares, converted options into 49,650 shares and was granted 24,520 shares, increasing direct ownership by 22% to 258,788 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SVP, CAO & Treasurer Mcleod Ian converted options into 6,432 shares, was granted 1,161 shares and covered exercise/tax liability with 2,230 shares, increasing direct ownership by 29% to 24,107 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Anika Therapeutics Inc.4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Anika Therapeutics Inc.4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Anika Therapeutics Inc.4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by President and CEO Griffin Stephen D.4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Vogt Susan L N was granted 14,164 shares, increasing direct ownership by 39% to 50,213 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Richard Stephen was granted 14,164 shares, increasing direct ownership by 42% to 47,871 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Larsen Glenn R. was granted 14,164 shares, increasing direct ownership by 39% to 50,258 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Jellison William R was granted 14,164 shares, increasing direct ownership by 227% to 20,403 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Henneman John B Iii was granted 14,164 shares, increasing direct ownership by 40% to 49,871 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Fischetti Gary P was granted 14,164 shares, increasing direct ownership by 52% to 41,613 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Conley Sheryl L was granted 14,164 shares, increasing direct ownership by 50% to 42,568 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Capper Joseph H was granted 14,164 shares, increasing direct ownership by 227% to 20,403 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- EVP, CFO & COO Griffin Stephen D. converted options into 12,840 shares and covered exercise/tax liability with 3,769 shares, increasing direct ownership by 1,134% to 9,871 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- New insider Mcleod Ian claimed ownership of 16,042 shares (SEC Form 3)3 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SVP, Chief Operations Officer Nunes Anne covered exercise/tax liability with 1,068 shares and converted options into 3,637 shares, increasing direct ownership by 14% to 20,654 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by EVP, CFO and Treasurer Griffin Stephen D.4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- EVP, General Counsel, Corp Sec Colleran David converted options into 6,448 shares and covered exercise/tax liability with 1,893 shares, increasing direct ownership by 10% to 47,954 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- President, CEO, Director Blanchard Cheryl R converted options into 25,132 shares and covered exercise/tax liability with 12,152 shares, increasing direct ownership by 7% to 197,320 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SVP, Chief Operations Officer Nunes Anne converted options into 2,561 shares and covered exercise/tax liability with 752 shares, increasing direct ownership by 11% to 18,085 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- EVP, General Counsel, Corp Sec Colleran David converted options into 7,663 shares and covered exercise/tax liability with 2,250 shares, increasing direct ownership by 14% to 43,399 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- President, CEO, Director Blanchard Cheryl R converted options into 30,060 shares and covered exercise/tax liability with 12,675 shares, increasing direct ownership by 10% to 184,340 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SVP, Chief Operations Officer Nunes Anne covered exercise/tax liability with 959 shares and converted options into 3,296 shares, increasing direct ownership by 17% to 16,276 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- EVP, General Counsel, Corp Sec Colleran David converted options into 5,465 shares and covered exercise/tax liability with 1,604 shares, increasing direct ownership by 11% to 37,986 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- President, CEO, Director Blanchard Cheryl R covered exercise/tax liability with 5,871 shares and converted options into 20,002 shares, increasing direct ownership by 9% to 166,955 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SVP, Chief Operations Officer Nunes Anne converted options into 2,491 shares and covered exercise/tax liability with 732 shares, increasing direct ownership by 15% to 13,479 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Vogt Susan L N was granted 5,771 shares, increasing direct ownership by 19% to 36,049 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Richard Stephen was granted 5,771 shares, increasing direct ownership by 21% to 33,707 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Larsen Glenn R. was granted 5,771 shares, increasing direct ownership by 19% to 36,094 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Jellison William R was granted 5,771 shares, increasing direct ownership by 1,233% to 6,239 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Henneman John B Iii was granted 5,771 shares, increasing direct ownership by 19% to 35,707 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Fischetti Gary P was granted 5,771 shares, increasing direct ownership by 27% to 27,449 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Conley Sheryl L was granted 5,771 shares, increasing direct ownership by 25% to 28,404 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Director Capper Joseph H was granted 5,771 shares, increasing direct ownership by 1,233% to 6,239 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Jellison William R was granted 468 shares, increasing direct ownership by 17% to 3,168 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Griffin Stephen D.4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Capper Joseph H was granted 468 shares (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- New insider Jellison William R claimed ownership of 2,700 shares (SEC Form 3)3 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- New insider Griffin Stephen D. claimed no ownership of stock in the company (SEC Form 3)3 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- New insider Capper Joseph H claimed no ownership of stock in the company (SEC Form 3)3 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Levitz Michael L4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Colleran David4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Nunes Anne4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Blanchard Cheryl R4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Blanchard Cheryl R converted options into 64,480 shares and covered exercise/tax liability with 27,980 shares, increasing direct ownership by 32% to 151,694 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Colleran David converted options into 16,809 shares and covered exercise/tax liability with 4,936 shares, increasing direct ownership by 56% to 32,995 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Nunes Anne converted options into 5,856 shares and covered exercise/tax liability with 1,720 shares, increasing direct ownership by 60% to 11,086 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Levitz Michael L converted options into 19,201 shares and covered exercise/tax liability with 5,638 shares, increasing direct ownership by 41% to 46,955 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- New insider Nunes Anne claimed ownership of 4,777 shares (SEC Form 3) (Amendment)3/A - Anika Therapeutics, Inc. (0000898437) (Issuer)
- Nunes Anne converted options into 2,491 shares and covered exercise/tax liability with 732 shares, increasing direct ownership by 53% to 5,052 units (SEC Form 4)4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4: Levitz Michael L converted options into 3,859 shares and covered exercise/tax liability with 1,133 shares, increasing direct ownership by 9% to 33,232 units4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 3: New insider Nunes Anne claimed ownership of 3,293 shares3 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Vogt Susan L N4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Thompson Jeffery S4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Larsen Glenn R.4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
- SEC Form 4 filed by Richard Stephen4 - Anika Therapeutics, Inc. (0000898437) (Issuer)